Lichtenegger Paul, Graf Alexandra, Schiefer Judith, Bilir Aylin, Kollmann Dagmar, Berlakovich Gabriela A, Faybik Peter, Baron David M, Baron-Stefaniak Joanna
Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Institute of Medical Statistics, Centre for Medical Data Science, Medical University of Vienna, Vienna, Austria.
BMC Anesthesiol. 2025 Apr 11;25(1):178. doi: 10.1186/s12871-025-03016-y.
Perioperative hypoalbuminemia has been associated with worse outcome after major surgery. Although hypoalbuminemia is common in patients with chronic liver disease and frequently occurs following liver transplantation (LT), data are sparse regarding perioperative hypoalbuminemia and outcome after LT.
In this single-center retrospective study performed at the Medical University of Vienna, we evaluated adult patients undergoing orthotopic liver transplantation (OLT) between 2004 and 2019. The association between perioperative serum albumin concentrations and survival, acute kidney injury (AKI), and postoperative surgical complications was analyzed using cox and logistic regression models.
In total, 724 patients were analyzed. Serum albumin concentrations decreased from 32.0 ± 6.8 to 22.8 ± 4.8 g/l (nadir within 48 h following OLT). Overall survival was not associated with serum albumin concentrations on day 1, day 2, or at nadir within 48 h after OLT (Day1: HR:0.988, 95%CI:0.966-1.011, P = 0.306; Day2: HR:1.021, 95%CI:0.991-1.052, P = 0.167; Nadir: HR:0.998, 95%CI:0.971-1.025, P = 0.863). Serum albumin concentrations on day 1, day 2, or at nadir within 48 h after OLT were not associated with AKI (Day1: OR:0.975, 95%CI:0.949-1.002, P = 0.070; Day2: OR:1.011, 95%CI:0.971-1.053, P = 0.601; Nadir: HR:0.976, 95%CI:0.940-1.013, P = 0.20) or with postoperative complications (Day1: OR:0.997, 95%CI:0.976-1.059, P = 0.80; Day2: OR:1.002, 95%CI:0.973-1.032, P = 0.890; Nadir: HR:0.993, 95%CI:0.966-1.021, P = 0.610). However, we observed an increased risk for initiation of renal replacement therapy with lower serum albumin concentrations on the day preceding initiation (HR = 0.946; 95%CI:0.896-1.000; P = 0.049).
Hypoalbuminemia was not associated with reduced survival, the development of AKI, or postoperative surgical complications after OLT. However, postoperative hypoalbuminemia was associated with the timing of initiating renal replacement therapy after OLT.
围手术期低白蛋白血症与大手术后更差的预后相关。尽管低白蛋白血症在慢性肝病患者中很常见,且在肝移植(LT)后经常发生,但关于围手术期低白蛋白血症及LT后预后的数据却很少。
在维也纳医科大学进行的这项单中心回顾性研究中,我们评估了2004年至2019年间接受原位肝移植(OLT)的成年患者。使用Cox和逻辑回归模型分析围手术期血清白蛋白浓度与生存率、急性肾损伤(AKI)及术后手术并发症之间的关联。
总共分析了724例患者。血清白蛋白浓度从32.0±6.8g/L降至22.8±4.8g/L(最低点在OLT后48小时内)。总体生存率与OLT后第1天、第2天或48小时内最低点时的血清白蛋白浓度无关(第1天:风险比[HR]:0.988,95%置信区间[CI]:0.966 - 1.011,P = 0.306;第2天:HR:1.021,95%CI:0.991 - 1.052,P = 0.167;最低点:HR:0.998,95%CI:0.971 - 1.025,P = 0.863)。OLT后第1天、第2天或48小时内最低点时的血清白蛋白浓度与AKI无关(第1天:比值比[OR]:0.975,95%CI:0.949 - 1.002,P = 0.070;第2天:OR:1.011,95%CI:0.971 - 1.053,P = 0.601;最低点:HR:0.976,95%CI:0.940 - 1.013,P = 0.20),也与术后并发症无关(第1天:OR:0.997,95%CI:0.976 - 1.059,P = 0.80;第2天:OR:1.002,95%CI:0.973 - 1.032,P = 0.890;最低点:HR:0.993,95%CI:0.966 - 1.021,P = 0.610)。然而,我们观察到在开始肾脏替代治疗前一天血清白蛋白浓度较低时,开始肾脏替代治疗的风险增加(HR = 0.946;95%CI:0.896 - 1.000;P = 0.049)。
低白蛋白血症与OLT后生存率降低、AKI的发生或术后手术并发症无关。然而,术后低白蛋白血症与OLT后开始肾脏替代治疗的时机有关。